CONCORD, Calif. (AP) _ Cerus Corp. (CERS) on Wednesday reported a loss of $18 million in its third quarter.
The Concord, California-based company said it had a loss of 13 cents per share.
The biomedical products company posted revenue of $18 million in the period.
Cerus expects full-year revenue in the range of $72 million to $75 million.
In the final minutes of trading on Wednesday, the company's shares hit $4.50. A year ago, they were trading at $6.29.